A new study offers hope in predicting glioblastoma responses to chemotherapy, radiation, and combination therapy.
Cancer and Genetics
Cancer Network spoke with Dr. Rachel Karchin about the contemporary search for cancer-driving gene mutations.
Cancer Network spoke with Dr. Chuan-Hsiang Huang about his lab’s research on Ras-ERK protein interactions within cancer cells.
Dr. William Newman spoke with Cancer Network about the roles of epigenetic silencing in heritable cancer syndromes.
Dr. Denise Faustman spoke with Cancer Network about TNFR2 and its emerging role in understanding regulatory T-cell behavior.
Dr. Raghu Kalluri speaks with Cancer Network about the role of exosomes in cancer progression ahead of his presentation at ESMO 2018.
The FDA authorized the first next-generation sequencing test to detect minimal residual disease in blood cancers.
A study shows gene variants of uncertain significance are frequently reclassified, necessitating amended test result reports.
A study finds EWSR1-ETS in 42% of cases via complex, loop-like rearrangements, rather than by simple reciprocal translocations.
A study shows significant association between MTHFR C677T polymorphisms and risk of oral squamous cell carcinoma.